Effect of treatment with ossein-hydroxyapatite compound on the time of fracture-healing". A prospective, multicenter, double-blind, randomised, placebo controlled clinical trial
Effect of treatment with ossein-hydroxyapatite compound on the time of fracture-healing". A prospective, multicenter, double-blind, randomised, placebo controlled clinical trial
Effect of treatment with ossein-hydroxyapatite compound on the time of fracture-healing". A prospective, multicenter, double-blind, randomised, placebo controlled clinical trial
Status
Status :
Completed
Type of study
Phase IV
Min. Age
50
Years old
Max. Age
80
Years old
Gender
All
Therapeutic area :
Muskuloskeletal
Disease :
Osteoporosis
Study medication :
Ossein Hydroxyapatite (Osteogenon)
Phase :
Phase IV
Start Date :
17 April 2011
End date :
20 June 2012
Study ID :
L00006 CP 405
EudraCT/CTIS number :
2010-020973-18
Send by email